Latest News about LGVN
Recent news which mentions LGVN
From Benzinga
From InvestorPlace
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
December 13, 2022
From Benzinga
7 trade ideas for next week
October 23, 2022
From AC Investor Blog
How to Find Stocks That Rise 10x
October 10, 2022
From InvestorPlace
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
October 05, 2022
From InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
September 29, 2022
From Benzinga
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 28, 2022
From Benzinga
From InvestorPlace
From Benzinga
From InvestorPlace
Why Is Longeveron (LGVN) Stock on the Move Today?
August 31, 2022
From InvestorPlace
Longeveron Shares Ascend As FDA Grants Fast Track Status To Congenital Heart Disease Candidate
August 31, 2022
Tickers
LGVN
From Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Product Gets US FDA Fast Track Designation For Treatment Of Hypoplastic Left Heart Syndrome in Infants
August 31, 2022
Tickers
LGVN
From Benzinga
European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods To Monitor Efficacy Of Lomecel-B™ Cell Therapy
August 26, 2022
Tickers
LGVN
From Benzinga
European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy
August 26, 2022
Tickers
LGVN
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 24, 2022
From Benzinga
Earnings Scheduled For August 12, 2022
August 12, 2022
From Benzinga
Is This Company In A Special Position Even As The COVID-19 Pandemic Affects Cell-Based Therapy Industry?
August 09, 2022
From Benzinga
Publication Of Peer-Reviewed Study In Journal Of The Alzheimer's Association Could Mark A Significant Step For Longeveron
August 02, 2022
From Benzinga
Aging Veterans May Have New Options As VA And Longeveron Make Progress On Clinical Research Of Aging Frailty Treatment
July 28, 2022
From Benzinga
7 Moonshot Investments Upending a $10 Trillion Industry
July 08, 2022
From InvestorPlace
From Benzinga
This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session
July 07, 2022
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.